Page last updated: 2024-09-04

edotreotide and Bone Cancer

edotreotide has been researched along with Bone Cancer in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Banerjee, SR; Pomper, MG	1
Baete, K; Bogaerts, K; Clement, PM; Deroose, CM; Haustermans, K; Koole, M; Mortelmans, L; Mottaghy, FM; Nackaerts, K; Terwinghe, C; Van Binnebeek, S; Van Cutsem, E; Vanbilloen, B; Verbruggen, A; Verslype, C	1
Cornelissen, C; Frechen, D; Krüger, S; Kweider, S; Temur, Y	1

Reviews

1 review(s) available for edotreotide and Bone Cancer

Article	Year
Clinical applications of Gallium-68. Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2013, Volume: 76 Topics: Bone Neoplasms; Chelating Agents; Citrates; Clinical Trials as Topic; Female; Gallium; Gallium Radioisotopes; Half-Life; Humans; Middle Aged; Multimodal Imaging; Neuroendocrine Tumors; Octreotide; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Somatostatin; Tomography, X-Ray Computed	2013

Article

Year

Clinical applications of Gallium-68.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2013, Volume: 76

Topics: Bone Neoplasms; Chelating Agents; Citrates; Clinical Trials as Topic; Female; Gallium; Gallium Radioisotopes; Half-Life; Humans; Middle Aged; Multimodal Imaging; Neuroendocrine Tumors; Octreotide; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Somatostatin; Tomography, X-Ray Computed

2013

Trials

1 trial(s) available for edotreotide and Bone Cancer

Article	Year
Comparison of diagnostic accuracy of (111)In-pentetreotide SPECT and (68)Ga-DOTATOC PET/CT: A lesion-by-lesion analysis in patients with metastatic neuroendocrine tumours. European radiology, 2016, Volume: 26, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Female; Gallium Radioisotopes; Humans; Liver Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Positron-Emission Tomography; Radiopharmaceuticals; Somatostatin; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed	2016

Article

Year

Comparison of diagnostic accuracy of (111)In-pentetreotide SPECT and (68)Ga-DOTATOC PET/CT: A lesion-by-lesion analysis in patients with metastatic neuroendocrine tumours.

European radiology, 2016, Volume: 26, Issue:3

Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Female; Gallium Radioisotopes; Humans; Liver Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Positron-Emission Tomography; Radiopharmaceuticals; Somatostatin; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed

2016

Other Studies

1 other study(ies) available for edotreotide and Bone Cancer

Article	Year
[Neuroendocrine pulmonary neoplasms: improved diagnosis by DOTATOC- vs. FDG-PET/CT]. Pneumologie (Stuttgart, Germany), 2011, Volume: 65, Issue:10 Topics: Biopsy; Bone Neoplasms; Carcinoma, Neuroendocrine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lumbar Vertebrae; Lung; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Octreotide; Positron-Emission Tomography; Ribs; Sacrum; Spinal Neoplasms; Tomography, X-Ray Computed	2011

Article

Year

[Neuroendocrine pulmonary neoplasms: improved diagnosis by DOTATOC- vs. FDG-PET/CT].

Pneumologie (Stuttgart, Germany), 2011, Volume: 65, Issue:10

Topics: Biopsy; Bone Neoplasms; Carcinoma, Neuroendocrine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lumbar Vertebrae; Lung; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Octreotide; Positron-Emission Tomography; Ribs; Sacrum; Spinal Neoplasms; Tomography, X-Ray Computed

2011